搜索临床试验以:ABI-007 (Abraxane)
总计4796个结果
-
Mt. Sinai Medical Center, MiamiCelgene Corporation完全的
-
Aevi Genomic Medicine, LLC, a Cerecor company完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI); National Comprehensive Cancer Network完全的
-
Fujian Medical University Union Hospital尚未招聘免疫疗法;Envafolimab;食道癌
-
University Hospital, GhentCentre Hospitalier Universitaire Vaudois; University Ghent; Hopital Lariboisière; Kom Op Tegen Kanker 和其他合作者完全的乳腺癌第四期 | 腹膜癌病 | 卵巢癌IIIC期 | 卵巢癌第四期 | 乳腺癌 IIIB 期 | 乳腺癌 IIIc 期 | 卵巢癌IIIB期 | 胃癌三期 | 转移性胃癌 IV 期 | 胰腺癌,III 期 | 胰腺癌,IV 期比利时
-
Celularity Incorporated完全的
-
Shouyao Holdings (Beijing) Co. LTD招聘中
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey撤销卵巢癌 | 子宫内膜癌 | 复发性子宫内膜癌 | 复发性卵巢癌
-
StimuSILAnkara City Hospital Bilkent; Istanbul University - Cerrahpasa (IUC)招聘中
-
Primo Biotechnology Co., LtdABX advanced biochemical compounds GmbH招聘中
-
Shouyao Holdings (Beijing) Co. LTD招聘中
-
JANSSEN Alzheimer Immunotherapy Research & Development...终止
-
Biocad招聘中
-
Azura OphthalmicsSyneos Health; Cliantha Research完全的
-
Selayang Hospital完全的
-
Shenzhen NewDEL Biotech, Co., LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.邀请报名
-
Sarit AssoulineNovartis招聘中
-
Nanjing Leads Biolabs Co.,LtdHenan Cancer Hospital; Hunan Cancer Hospital; Shandong Cancer Hospital and Institute完全的
-
Aadi Bioscience, Inc.批准上市TSC1 | TSC2 | PEComa,恶性 | mTOR 通路畸变
-
McGill University Health Centre/Research Institute...Université de Montréal; Argos Therapeutics完全的
-
The Christie NHS Foundation TrustNovartis; East and North Hertfordshire NHS Trust; Mateon Therapeutics终止
-
Celgene完全的